Mersana Therapeutics, Inc. Lease, Cost
Mersana Therapeutics, Inc. reported Lease, Cost of $3.39 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-02-28
- Mersana Therapeutics, Inc. lease, cost for fiscal 2021 was $3.39M, a 28.21% increase from fiscal 2020.
- Mersana Therapeutics, Inc. lease, cost for fiscal 2020 was $2.64M, a 22.41% increase from fiscal 2019.
- Mersana Therapeutics, Inc. lease, cost for fiscal 2019 was $2.16M, a 8.32% increase from fiscal 2018.
- Mersana Therapeutics, Inc. lease, cost for fiscal 2018 was $1.99M.
| Period end | Lease, Cost 12 month |
|---|---|
| 2021-12-31 | $3.39M 10-K · filed 2022-02-28 |
| 2020-12-31 | $2.64M 10-K · filed 2022-02-28 |
| 2019-12-31 | $2.16M 10-K · filed 2022-02-28 |
| 2018-12-31 | $1.99M 10-K · filed 2021-02-26 |